New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

New Therapies for Treating Hepatitis C Virus: Impact on Laboratory Testing Recommendations and Clinical Management

[...]gaps in physician knowledge may result in inappropriate or less effective screening in primary care settings. Since the implementation of tissue and blood product HCV testing, the risk of HCV infection from a blood transfusion in the US has decreased from 33% to

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical chemistry 2017-12, Vol.63 (12), p.1799-1805
Hauptverfasser: Tolan, Nicole V, Horowitz, Gary L, Graham, Camilla S, Hillyard, David, Osburn, William, Ray, Stuart
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies - analysis
Baby boomers
Biological Assay
Blood transfusion
Drugs
Genotypes
Health care access
Hepacivirus - genetics
Hepacivirus - immunology
Hepatitis
Hepatitis C
Hepatitis C, Chronic - diagnosis
Hepatitis C, Chronic - drug therapy
Humans
Immunoassay
Immunoglobulins
Infections
Laboratory tests
Mass Screening
Medical diagnosis
Medical laboratories
Population
Primary care
Public health
RNA, Viral - analysis
Substance abuse treatment
Viruses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]gaps in physician knowledge may result in inappropriate or less effective screening in primary care settings. Since the implementation of tissue and blood product HCV testing, the risk of HCV infection from a blood transfusion in the US has decreased from 33% to
ISSN:0009-9147
1530-8561
DOI:10.1373/clinchem.2016.266569